AbCellera Biologics Inc. - Ordinary Shares (ABCL)

Historical Holders from Q4 2020 to Q3 2025

Symbol
ABCL on Nasdaq
Type / Class
Equity / Ordinary Shares
Shares outstanding
293M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
104M
Holdings value
$525M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
140
Number of buys
76
Number of sells
-57
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of AbCellera Biologics Inc. - Ordinary Shares (ABCL)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BAILLIE GIFFORD & CO 4.4% $32.9M 12.9M BAILLIE GIFFORD & CO 30 Sep 2024

Institutional Holders of AbCellera Biologics Inc. - Ordinary Shares (ABCL)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 104M $525M +$3.62M $5.03 140
2025 Q2 108M $371M -$42.1M $3.43 127
2025 Q1 125M $279M +$21.8M $2.23 127
2024 Q4 114M $334M +$23.9M $2.93 145
2024 Q3 106M $275M -$27.5M $2.60 139
2024 Q2 114M $338M -$13M $2.96 146
2024 Q1 121M $546M +$6.44M $4.53 153
2023 Q4 119M $681M -$3.74M $5.71 141
2023 Q3 120M $552M -$29.5M $4.60 137
2023 Q2 125M $809M -$42.7M $6.46 167
2023 Q1 130M $981M +$9.96M $7.54 181
2022 Q4 139M $1.41B +$65M $10.13 198
2022 Q3 132M $1.31B +$126M $9.89 185
2022 Q2 118M $1.26B +$77.6M $10.65 160
2022 Q1 113M $1.1B -$30.9M $9.75 126
2021 Q4 115M $1.63B +$98.2M $14.30 120
2021 Q3 98.7M $1.98B +$156M $20.04 115
2021 Q2 90.6M $1.99B +$169M $22.00 111
2021 Q1 71.1M $2.42B +$64.1M $33.96 82
2020 Q4 68.1M $2.74B +$2.59B $40.24 58